Back to Search
Start Over
622 A phase 1 study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor, INCB099318, in patients with select advanced solid tumors
- Source :
- Regular and Young Investigator Award Abstracts.
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group Ltd, 2022.
Details
- Database :
- OpenAIRE
- Journal :
- Regular and Young Investigator Award Abstracts
- Accession number :
- edsair.doi...........588fc81a0353a39435e2c58342cbb09c